Skip to main content

Advertisement

Log in

Experience using denosumab for lung metastases of giant cell tumor of bone

  • Case Report
  • Published:
European Orthopaedics and Traumatology

Abstract

The treatment of unresectable multiple lung metastasis of giant cell tumor of bone (GCTB) is challenging. In the current manuscript, we present a case who presented with multiple lung metastases of GCTB and was successfully managed with the use of denosumab allowing for surgical resection of the metastatic lesions that was previously deemed unresectable. Pathologic examination also clearly demonstrated the histological effects of denosumab. We emphasize on effective response to denosumab even in metastatic GCTB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig 2
Fig 3

Similar content being viewed by others

References

  1. Thomas DM, Skubitz KM (2009) Giant cell tumor of bone. Curr Opin Oncol 21:338–344

    Article  PubMed  Google Scholar 

  2. Szendroi M (2004) Gian t-cell tumour of bone. J Bone Joint Surg Br 86:5–12

    CAS  PubMed  Google Scholar 

  3. Frank MK, Doris EW, Carrie Y et al (2011) Recurrent giant cell tumor of long bones: analysis of surgical management. In wards. Clin Orthop Relat Res 469(4):1181–1187

    Article  Google Scholar 

  4. Campanacci M, Baldini N, Boriani S et al (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69:106–114

    CAS  PubMed  Google Scholar 

  5. Thomas D, Henshaw R, Skubitz K et al (2010) Denosumab in patients with giant-cell tumor of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280

    Article  CAS  PubMed  Google Scholar 

  6. Nicole AK, Polgreen LE, Ogilvie C et al (2013) Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year old girl. J Clin Oncol 31:e200–e202

    Article  Google Scholar 

  7. Bekker PJ, Holloway DL, Rasmussen AS et al (2004) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 19:1059–1066

    Article  CAS  PubMed  Google Scholar 

  8. Bullough PG, Bansal M (2002) Malignancy in giant cell tumour. In: Fletcher CDM, Unni K, Mertens F (eds) World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone. International Agency for Research on Cancer (IARC), Lyon

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

The patient was informed that data from the case would be submitted for publication and gave his consent.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsunori Kaya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watanabe, Y., Kaya, M., Sasaki, M. et al. Experience using denosumab for lung metastases of giant cell tumor of bone. Eur Orthop Traumatol 6, 239–241 (2015). https://doi.org/10.1007/s12570-015-0308-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12570-015-0308-0

Keywords

Navigation